SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-060854
Filing Date
2024-03-06
Accepted
2024-03-06 17:16:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 d796211d424b5.htm 424B5 527315
2 EX-FILING FEES d796211dexfilingfees.htm EX-FILING FEES 34468
3 GRAPHIC g796211g01a53.jpg GRAPHIC 32765
4 GRAPHIC g796211g48x87.jpg GRAPHIC 57030
5 GRAPHIC g796211g60v54.jpg GRAPHIC 26719
6 GRAPHIC g796211g85g63.jpg GRAPHIC 30000
7 GRAPHIC g796211g88o37.jpg GRAPHIC 55765
  Complete submission text file 0001193125-24-060854.txt   842202
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256229 | Film No.: 24727037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)